References
1. Brown JM, O’Brien SM, Wu C, Sikora JAH, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg . 2009;137(1):82-90.
2. Schoen FJ, Levy RJ. Founder’s Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, April 28-May 2, 1999. Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res . 1999;47(4):439-465.
3. Head SJ, Çelik M, Kappetein AP. Mechanical versus bioprosthetic aortic valve replacement. Eur Heart J . 2017;38(28):2183-2191.
4. Biancari F, Valtola A, Juvonen T, et al. Trifecta versus Perimount Magna Ease Aortic Valve Prostheses. Ann Thorac Surg . Published online February 12, 2020.
5. Kume Y, Fujita T, Fukushima S, et al. Reducing Prosthesis-Patient Mismatch With Edwards Magna Prosthesis for Aortic Valve Replacement.Circ J Off J Jpn Circ Soc . 2017;81(4):468-475.
6. Fiegl K, Deutsch M-A, Rondak I-C, Lange R, Guenzinger R. Matched Comparison of Two Different Biological Prostheses for Complete Supra-annular Aortic Valve Replacement. Thorac Cardiovasc Surg . 2015;63(6):459-466.
7. Nishioka N, Yamada A, Ujihira K, et al. Outcomes of surgical aortic valve replacement using Carpentier-Edwards PERIMOUNT bioprosthesis series in elderly patients with severe aortic valve stenosis: a retrospective cohort study. Gen Thorac Cardiovasc Surg . 2016;64(12):728-734.
8. Wendt D, Thielmann M, Plicht B, et al. The new St Jude Trifecta versus Carpentier-Edwards Perimount Magna and Magna Ease aortic bioprosthesis: is there a hemodynamic superiority? J Thorac Cardiovasc Surg . 2014;147(5):1553-1560.
9. Bach DS, Patel HJ, Kolias TJ, Deeb GM. Randomized comparison of exercise haemodynamics of Freestyle, Magna Ease and Trifecta bioprostheses after aortic valve replacement for severe aortic stenosis.Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg . 2016;50(2):361-367.
10. Bavaria JE, Desai ND, Cheung A, et al. The St Jude Medical Trifecta aortic pericardial valve: results from a global, multicenter, prospective clinical study. J Thorac Cardiovasc Surg . 2014;147(2):590-597.
11. Colli A, Marchetto G, Salizzoni S, et al. The TRIBECA study: (TRI)fecta (B)ioprosthesis (E)valuation versus (C)arpentier Magna-Ease in (A)ortic position. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg . 2016;49(2):478-485.
12. Stock S, Lohmann I, Hanke T, et al. Rest and exercise haemodynamics in patients with one of two stented bioprostheses and in healthy controls with small aortic annuli. Interact Cardiovasc Thorac Surg . 2018;26(3):425-430.
13. Domoto S, Niinami H, Uwabe K, et al. Comparison of early haemodynamics of 19-mm aortic valve bioprostheses in patients with a small aortic annulus. Interact Cardiovasc Thorac Surg . 2016;22(1):19-25.
14. Ugur M, Suri RM, Daly RC, et al. Comparison of early hemodynamic performance of 3 aortic valve bioprostheses. J Thorac Cardiovasc Surg . 2014;148(5):1940-1946.
15. Yanagawa B, Tam DY, Hong K, et al. Magna Ease Versus Trifecta Early Hemodynamics: A Systematic Review and Meta-analysis. Innov Phila Pa . 2018;13(4):267-272.
16. Rubens FD, Gee Y-Y, Ngu JMC, Chen L, Burwash IG. Effect of aortic pericardial valve choice on outcomes and left ventricular mass regression in patients with left ventricular hypertrophy. J Thorac Cardiovasc Surg . 2016;152(5):1291-1298.e2.
17. Goldman S, Cheung A, Bavaria JE, Petracek MR, Groh MA, Schaff HV. Midterm, multicenter clinical and hemodynamic results for the Trifecta aortic pericardial valve. J Thorac Cardiovasc Surg . 2017;153(3):561-569.e2.
18. Fukuhara S, Shiomi S, Yang B, et al. Early Structural Valve Degeneration of Trifecta Bioprosthesis. Ann Thorac Surg . 2020;109(3):720-727.
19. Theologou T, Harky A, Shaw M, et al. Mitroflow and Perimount Magna 10 years outcomes a direct propensity match analysis to assess reintervention rates and long follow-up mortality. J Card Surg . 2019;34(11):1279-1287.
20. Johnston DR, Soltesz EG, Vakil N, et al. Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants.Ann Thorac Surg . 2015;99(4):1239-1247.
21. Glaser N, Franco-Cereceda A, Sartipy U. Late survival after aortic valve replacement with the perimount versus the mosaic bioprosthesis.Ann Thorac Surg . 2014;97(4):1314-1320.
22. Kilic A, Sultan I, Navid F, et al. Trifecta Aortic Bioprosthesis: Midterm Results in 1,953 Patients From a Single Center. Ann Thorac Surg . 2019;107(5):1356-1362.
23. Lehmann S, Meyer A, Schroeter T, et al. Midterm Durability and Hemodynamic Performance of a Third-Generation Bovine Pericardial Prosthetic Aortic Valve: The Leipzig Experience. Ann Thorac Surg . 2017;103(6):1933-1939.
24. Kalra A, Rehman H, Ramchandani M, et al. Early Trifecta valve failure: Report of a cluster of cases from a tertiary care referral center. J Thorac Cardiovasc Surg . 2017;154(4):1235-1240.
25. Kaneyuki D, Nakajima H, Asakura T, et al. Early First-Generation Trifecta Valve Failure: A Case Series and a Review of the Literature.Ann Thorac Surg . 2020;109(1):86-92.
26. Hernandez-Vaquero D, Diaz R, Pascual I, et al. The Prevalence of Patient-Prosthesis Mismatch Can Be Reduced Using the Trifecta Aortic Prosthesis. Ann Thorac Surg . 2018;105(1):144-151.
27. Rodriguez-Gabella T, Voisine P, Puri R, Pibarot P, Rodés-Cabau J. Aortic Bioprosthetic Valve Durability: Incidence, Mechanisms, Predictors, and Management of Surgical and Transcatheter Valve Degeneration. J Am Coll Cardiol . 2017;70(8):1013-1028.
28. Anselmi A, Ruggieri VG, Lelong B, et al. Mid-term durability of the Trifecta bioprosthesis for aortic valve replacement. J Thorac Cardiovasc Surg . 2017;153(1):21-28.e1.